Results 261 to 270 of about 341,590 (292)
Some of the next articles are maybe not open access.
Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis
Arthritis & Rheumatology, 2020Neutrophils are key immune cells participating in host defense through several mechanisms, including the formation of neutrophil extracellular traps (NETs). This study was undertaken to investigate the role of neutrophils in juvenile dermatomyositis (JDM)
Bhargavi Duvvuri +7 more
semanticscholar +1 more source
International Journal of Rheumatic Diseases, 2021
Tofacitinib has an important role in pediatric rapidly progressive interstitial lung disease (ILD) associated with juvenile dermatomyositis (JDM), an otherwise potentially fatal condition. It may be useful in induction of remission and can be used safely
Poh Lin Pauline Chan Ng +7 more
semanticscholar +1 more source
Tofacitinib has an important role in pediatric rapidly progressive interstitial lung disease (ILD) associated with juvenile dermatomyositis (JDM), an otherwise potentially fatal condition. It may be useful in induction of remission and can be used safely
Poh Lin Pauline Chan Ng +7 more
semanticscholar +1 more source
2013
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Romain K. Gherardi, Pierre Quartier
openaire +3 more sources
Juvenile dermatomyositis (JDM) is a systemic, inflammatory, idiopathic disease, mainly affecting the skin and the muscles, starting before the age of 16, with an incidence around one case per 1 million children. Some patients display typical features of JDM without skin involvement, or even without muscle involvement; however, both tissues are affected
Romain K. Gherardi, Pierre Quartier
openaire +3 more sources
International Journal of Rheumatic Diseases, 2021
Patients with juvenile dermatomyositis (JDM) experience muscle weakness, tiredness, and loss of energy, which restrict their abilities in performance of their daily living activities.
R. Elnaggar, Walaa A. Abd El-Nabie
semanticscholar +1 more source
Patients with juvenile dermatomyositis (JDM) experience muscle weakness, tiredness, and loss of energy, which restrict their abilities in performance of their daily living activities.
R. Elnaggar, Walaa A. Abd El-Nabie
semanticscholar +1 more source
Juvenile amyopathic dermatomyositis
British Journal of Dermatology, 1997We report a 15-year-old girl with a 10-year-old history of typical skin features of dermatomyositis (DM) without evidence of muscle involvement. Amyopathic dermatomyositis (ADM) is defined by the presence of biopsy confirmed classic cutaneous findings of dermatomyositis in the absence of any clinical or laboratory signs of muscle disease for at least 2
R.M. Trüeb, M. H. Schmid
openaire +3 more sources
Medical Clinics of North America, 1989
Juvenile dermatomyositis is a chronic disease of childhood that is manifested by severe symmetrical progressive muscle weakness, a characteristic heliotrope colored skin rash which involves the face, and by elevated serum enzymes related to muscle damage.
openaire +2 more sources
Juvenile dermatomyositis is a chronic disease of childhood that is manifested by severe symmetrical progressive muscle weakness, a characteristic heliotrope colored skin rash which involves the face, and by elevated serum enzymes related to muscle damage.
openaire +2 more sources
CYCLOSPORIN IN JUVENILE DERMATOMYOSITIS
The Lancet, 1989Juvenile dermatomyositis in fourteen children who had not responded fully to steroids and other immunosuppressants and who had had chronic active disease for an average of 3 years was successfully treated with cyclosporin. Twelve patients had serious complications of the disease or of previous treatment. The response to cyclosporin included recovery of
Marlene L. Rose +8 more
openaire +3 more sources
Retinopathy in juvenile dermatomyositis
The Journal of Pediatrics, 19761. Hughes WT, Feldman S, and Cox F: Infectious diseases in children with cancer, Pediatr Clin North Am 21:583, 1974. 2. Gold E: Serologic and virus-isolation studies on patients with varicella or herpes zoster infections, N Engl J Med 174:181, 1966. 3.
L.S. Fruman +3 more
openaire +3 more sources
Calcinosis in juvenile dermatomyositis
Postgraduate Medical Journal, 2010A 61-year-old Caucasian man presented with widespread soft tissue calcinosis. Juvenile dermatomyositis (JDM) had been diagnosed at the age of 12 years, and was treated at the time with high dose corticosteroid. His myositis had been in remission since the age of 16 years, with no new muscle weakness and a normal creatine kinase concentration.
Nicola Tugnet, David H E Rees
openaire +3 more sources
Readability of online patient education materials for juvenile dermatomyositis
Pediatric dermatology, 2021In this study, we sought to analyze the readability of online patient education materials (PEMs) related to juvenile dermatomyositis (JDM). We analyzed the top 100 Google results and using six different readability scores, found 53 PEMs which had an ...
Melissa A. Nickles +4 more
semanticscholar +1 more source